drugset / Trial / NCT02158689

Comparison of Treatment Modalities in Poor Responders Undergoing IVF

NCT02158689

Completed 80 enrolled Ercan Bastu
RandomizedParallel-groupOpen-labelTreatment

Summary

The accurate identification and efficient management of poor responders remains one of the most enigmatic challenges in assisted reproductive technology (ART). The investigators study will compare the letrozole/antagonist protocol to the hMG/antagonist protocol in women who poor responders.

Timeline

Start
2014-06
Primary completion
2015-08
Completion
2015-08

Drugs

EvaluationDrugModalityDoseRoute
Comparator Letrozole Other / unclassified 5 mg
Comparator human chorionic gonadotropin Protein / enzyme biologic 150 iu
Comparator human chorionic gonadotropin Protein / enzyme biologic 300 iu

Indications

No indication recorded.